Wisconsin Assembly Bill AB748

Wisconsin 2023-2024 Regular Session

• Introduced: 12/6/23
• Refer: 12/6/23
• Failed: 4/15/24

Caption

Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)

Impact

The bill imposes a cap on the monthly cost-sharing for insulin, limiting it to a maximum of $35 for a one-month supply. This provision is particularly important given the rising costs of diabetes care, which can be prohibitive for many households. Furthermore, it mandates that insulin manufacturers establish safety net programs to ensure that uninsured residents in urgent need can acquire insulin without prohibitive costs. These measures are expected to alleviate some financial pressure on families managing chronic conditions and support better health outcomes.

Summary

Assembly Bill 748 focuses on improving healthcare affordability and access, specifically targeting prescription drugs and diabetes management. One of the key features of the bill is the elimination of cost-sharing payments for individuals enrolled in the Medical Assistance program, commonly referred to as BadgerCare. This move aims to reduce financial barriers for low-income patients when it comes to accessing necessary medications, thereby enhancing health equity within the state.

Contention

Notable points of contention include the regulatory implications on pharmacy benefit managers (PBMs), who are required to adhere to new fiduciary and disclosure standards under the bill. This change has prompted debate among stakeholders about the potential impact on pharmaceutical pricing practices and the overall efficiency of medication distribution. Additionally, the bill encourages the establishment of a state prescription drug purchasing entity, which may challenge current supplier contracts and purchasing dynamics, heightening tensions among drug manufacturers and local pharmacies.